JP2023506450A5 - - Google Patents
Info
- Publication number
- JP2023506450A5 JP2023506450A5 JP2022535512A JP2022535512A JP2023506450A5 JP 2023506450 A5 JP2023506450 A5 JP 2023506450A5 JP 2022535512 A JP2022535512 A JP 2022535512A JP 2022535512 A JP2022535512 A JP 2022535512A JP 2023506450 A5 JP2023506450 A5 JP 2023506450A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical product
- product according
- individual
- antibody
- effective amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2019904682A AU2019904682A0 (en) | 2019-12-11 | Compositions and methods for prevention and treatment of cardiovascular disease. | |
| AU2019904682 | 2019-12-11 | ||
| PCT/AU2020/051254 WO2021113899A1 (en) | 2019-12-11 | 2020-11-20 | Therapeutic compositions comprising an amyloid beta antibody or vaccine for prevention and treatment of diastolic dysfunction |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023506450A JP2023506450A (ja) | 2023-02-16 |
| JP2023506450A5 true JP2023506450A5 (https=) | 2023-12-13 |
Family
ID=76328764
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022535512A Pending JP2023506450A (ja) | 2019-12-11 | 2020-11-20 | 拡張機能障害の防止及び治療のためのアミロイドベータ抗体又はワクチンを含む療法組成物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20230027014A1 (https=) |
| EP (1) | EP4073113A4 (https=) |
| JP (1) | JP2023506450A (https=) |
| AU (1) | AU2020401837A1 (https=) |
| WO (1) | WO2021113899A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20230039734A (ko) | 2020-07-23 | 2023-03-21 | 오타이르 프로테나 리미티드 | 항-Aβ 항체 |
| WO2025165940A1 (en) * | 2024-02-01 | 2025-08-07 | Calviri, Inc. | Methods and compositions for reducing non-tumor disease |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA200501524A1 (ru) * | 2003-03-28 | 2006-06-30 | Сентокор, Инк. | Антитела против амилоида, композиции, способы и применения |
| EP1959996A2 (en) * | 2005-12-12 | 2008-08-27 | AC Immune S.A. | Monoclonal antibody |
| US20100028351A1 (en) * | 2006-06-29 | 2010-02-04 | Marc Mercken | Anti-amyloid antibodies, compositions, methods and uses |
| DK2182983T3 (da) * | 2007-07-27 | 2014-07-14 | Janssen Alzheimer Immunotherap | Behandling af amyloidogene sygdomme med humaniserede anti-abeta antistoffer |
| US20100074901A1 (en) * | 2007-10-15 | 2010-03-25 | Marc Hubert Mercken | Human anti-amyloid antibodies, compositions, methods and uses |
| US20110178024A1 (en) * | 2008-09-29 | 2011-07-21 | Ben Gurion University Of The Negev Research And Development Authority | Amyloid beta-peptides and methods of use thereof |
| US20130084245A1 (en) * | 2010-02-25 | 2013-04-04 | Wyeth Llc | Pet monitoring of a-beta-directed immunotherapy |
| AU2020401838A1 (en) * | 2019-12-11 | 2022-07-21 | Ambetex Pty Ltd | Therapeutic compositions and methods for prevention and treatment of diastolic dysfunction |
-
2020
- 2020-11-20 AU AU2020401837A patent/AU2020401837A1/en active Pending
- 2020-11-20 JP JP2022535512A patent/JP2023506450A/ja active Pending
- 2020-11-20 EP EP20899767.6A patent/EP4073113A4/en not_active Withdrawn
- 2020-11-20 US US17/784,585 patent/US20230027014A1/en active Pending
- 2020-11-20 WO PCT/AU2020/051254 patent/WO2021113899A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hausenloy et al. | Ischaemic conditioning and reperfusion injury | |
| Opolski et al. | Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study | |
| JP2021504423A5 (https=) | ||
| JP2011522876A (ja) | 永続性心房細動を予防するためのドロネダロン | |
| JP2024075655A5 (ja) | 鏡像異性体的に純粋なブプロピオンの医薬の製造における使用 | |
| Thind et al. | Ventricular aneurysmectomy for the treatment of recurrent ventricular tachyarrhythmia | |
| JP2024540183A5 (https=) | ||
| Parker et al. | Nitroglycerin lingual spray: clinical efficacy and dose-response relation | |
| JP2023540485A5 (https=) | ||
| JP2023506450A5 (https=) | ||
| JP2014139255A5 (https=) | ||
| Kumagai et al. | Single oral administration of pilsicainide versus infusion of disopyramide for termination of paroxysmal atrial fibrillation: a multicenter trial | |
| JP2025509278A5 (https=) | ||
| JP5396387B2 (ja) | 心臓不整脈を治療するためのｄ−リボースの用途 | |
| Rajpal et al. | Non-ST-elevation myocardial infarction with the use of oxymetazoline nasal spray | |
| JP2008534621A5 (https=) | ||
| Verdecchia et al. | Treatment strategies for osteoarthritis patients with pain and hypertension | |
| JP2021511352A5 (https=) | ||
| Meinertz et al. | Trapidil is as effective as isosorbidedinitrate for treating stable angina pectoris— A multinational, multicenter, double-blind, randomized study | |
| Grimm | What is evidence-based, what is new in medical therapy of acute heart failure? | |
| JP2019504085A5 (https=) | ||
| Donoiu et al. | Ventricular septal rupture after acute myocardial infarction | |
| Van Stuijvenberg et al. | Pharmacological treatment of young children with permanent junctional reciprocating tachycardia | |
| Steinbrook | Preventing HIV infection in children | |
| Nair | Myopericarditis: case report |